Cormorant Asset Management’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-286,200
| Closed | -$670K | – | 86 |
|
|
2015
Q3 | $670K | Hold |
286,200
| – | – | 0.11% | 79 |
|
|
2015
Q2 | $781K | Hold |
286,200
| – | – | 0.1% | 74 |
|
|
2015
Q1 | $959K | Sell |
286,200
-25,800
| -8% | -$86.5K | 0.15% | 63 |
|
|
2014
Q4 | $1.08M | Sell |
312,000
-138,400
| -31% | -$480K | 0.17% | 59 |
|
|
2014
Q3 | $2.27M | Sell |
450,400
-349,600
| -44% | -$1.76M | 0.47% | 46 |
|
|
2014
Q2 | $11M | Buy |
800,000
+452,000
| +130% | +$6.24M | 2.93% | 12 |
|
|
2014
Q1 | $5.33M | Buy |
+348,000
| New | +$5.33M | 1.23% | 29 |
|